Al- Anbar Medical Journal

Are Smoker/Vapers at Risk of Severe COVID-19 Infection?

Document Type : Editorial article

Authors

1 Department of Molecular and Medical Biotechnology,

2 Department of Biotechnology, College of Science, University of Anbar, Anbar, Iraq

3 Department of Oral and Maxillofacial Surgery, College of Dentistry, University of Anbar, Anbar, Iraq

Abstract

The recent outbreak of a novel coronavirus has put the world on alert. The World Health Organization (WHO) declared the novel coronavirus disease-2019 (COVID-19) as a pandemic and it has been spreading around the world rapidly [1]. The causative pathogen of a novel coronavirus was subsequently identified and named 2019 novel coronavirus (2019-nCoV). Pneumonia caused by new coronavirus is an acute respiratory infection caused by a coronavirus which is a positive-strand RNA and transmitted from the bat with high homology of a previously identified virus.

Keywords

Main Subjects

References
[1]      S. H. Aktimur, S. E. N. Ahmet, B. Yazicioglu, A. K. Gunes, and G. Serhat, “The Assessment of the Relationship Between ABO Blood Groups and Covid-19 Infection,” Int. J. Hematol. Oncol., vol. 30, no. 2, pp. 1–5, 2020.
[2]      S. A. Glantz, "Reduce your risk of serious lung disease caused by coronavirus by quitting smoking and vaping." 2020.
[3]      M. D. Aronson, S. T. Weiss, R. L. Ben, and A. L. Komaroff, “Association between cigarette smoking and acute respiratory tract illness in young adults,” Jama, vol. 248, no. 2, pp. 181–183, 1982.
[4]      S. J. Brake, K. Barnsley, W. Lu, K. D. McAlinden, M. S. Eapen, and S. S. Sohal, “Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19).” Multidisciplinary Digital Publishing Institute, 2020.
[5]      G. Cai, Y. Bossé, F. Xiao, F. Kheradmand, and C. I. Amos, “Tobacco smoking increases the lung gene expression of ACE2, the receptor of SARS-CoV-2,” Am. J. Respir. Crit. Care Med., no. ja, 2020.
[6]      M. A. Chilvers, M. McKean, A. Rutman, B. S. Myint, M. Silverman, and C. O’Callaghan, “The effects of coronavirus on human nasal ciliated respiratory epithelium,” Eur. Respir. J., vol. 18, no. 6, pp. 965–970, 2001.
[7]      R. Patanavanich and S. A. Glantz, “Smoking is associated with COVID-19 progression: a meta-analysis,” Nicotine Tob. Res., 2020.
[8]      E. editorial Team, “Updated rapid risk assessment from ECDC on coronavirus disease (COVID-19) pandemic in the EU/EEA and the UK: resurgence of cases,” Eurosurveillance, vol. 25, no. 32, p. 2008131, 2020.
[9]      J. Gu and C. Korteweg, “Pathology and pathogenesis of severe acute respiratory syndrome,” Am. J. Pathol., vol. 170, no. 4, pp. 1136–1147, 2007.
[10]    T. S. Henry, J. P. Kanne, and S. J. Kligerman, “Imaging of vaping-associated lung disease,” N. Engl. J. Med., vol. 381, no. 15, pp. 1486–1487, 2019.
[11]    C. Huang et al., “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China,” Lancet, vol. 395, no. 10223, pp. 497–506, 2020.
[12]    D. S. Hui, “Severe acute respiratory syndrome (SARS): lessons learnt in Hong Kong,” J. Thorac. Dis., vol. 5, no. Suppl 2, p. S122, 2013.
[13]    E. Javelle, “Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic,” Arch. Toxicol., pp. 1–2, 2020.
[14]    E. Kindler and V. Thiel, “SARS-CoV and IFN: too little, too late,” Cell Host Microbe, vol. 19, no. 2, pp. 139–141, 2016.
[15]    J. M. Leung et al., “ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19,” Eur. Respir. J., vol. 55, no. 5, 2020.
Al- Anbar Medical Journal
Volume 17, Issue 1
June 2021
Page 1-2
Files
Share
Export Citation
Statistics